Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis

被引:103
作者
Silva, PEA
Bigi, F
Santangelo, MD
Romano, MI
Martín, C
Cataldi, A
Aínsa, JA
机构
[1] Univ Zaragoza, Fac Med, Dept Microbiol Med Prevent & Salud Publ, E-50009 Zaragoza, Spain
[2] INTA, CICV, Inst Biotechnol, RA-1708 Moron, Argentina
关键词
D O I
10.1128/AAC.45.3.800-804.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Mycobacterium bovis P55 gene, located downstream from the gene that encodes the immunogenic lipoprotein P27, has been characterized. The gene was identical to the open reading frame of the Rv1410c gene in the genome of Mycobacterium tuberculosis H37Rv, annotated as a probable drug efflux protein. Genes similar to P55 were present in all species of the M. tuberculosis complex and other mycobacteria such as Mycobacterium leprae and Mycobacterium avium, By Western blotting, P55 was located in the membrane fraction of M. bovis, When transformed into Mycobacterium smegmatis after cloning, P55 conferred aminoglycoside and tetracycline resistance, The levels of resistance to streptomycin and tetracycline conferred by P55 were decreased in the presence of the protonophore carbonyl cyanide m-chlorophenylhydrazone and the pump inhibitors verapamil and reserpine, M. smegmatis cells expressing the plasmid-encoded P55 accumulated less tetracycline than the control cells. We conclude that P55 is a membrane protein implicated in aminoglycoside and tetracycline efflux in mycobacteria.
引用
收藏
页码:800 / 804
页数:5
相关论文
共 30 条
[21]  
Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002
[22]   Multidrug-resistant Mycobacterium tuberculosis: Molecular perspectives [J].
Rattan, A ;
Kalia, A ;
Ahmad, N .
EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :195-209
[23]   AcrD of Escherichia coli is an aminoglycoside efflux pump [J].
Rosenberg, EY ;
Ma, D ;
Nikaido, H .
JOURNAL OF BACTERIOLOGY, 2000, 182 (06) :1754-1756
[24]   Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria [J].
Saier, MH ;
Paulsen, IT ;
Sliwinski, MK ;
Pao, SS ;
Skurray, RA ;
Nikaido, H .
FASEB JOURNAL, 1998, 12 (03) :265-274
[25]   Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis [J].
Samper, S ;
Martin, C ;
Pinedo, A ;
Rivero, A ;
Blazquez, J ;
Baquero, F ;
vanSoolingen, D ;
vanEmbden, J .
AIDS, 1997, 11 (10) :1237-1242
[26]   Mycobacteria:: Genetics of resistance and implications for treatment [J].
Sander, P ;
Böttger, EC .
CHEMOTHERAPY, 1999, 45 (02) :95-108
[27]   ISOLATION AND CHARACTERIZATION OF EFFICIENT PLASMID TRANSFORMATION MUTANTS OF MYCOBACTERIUM-SMEGMATIS [J].
SNAPPER, SB ;
MELTON, RE ;
MUSTAFA, S ;
KIESER, T ;
JACOBS, WR .
MOLECULAR MICROBIOLOGY, 1990, 4 (11) :1911-1919
[28]   NEW USE OF BCG FOR RECOMBINANT VACCINES [J].
STOVER, CK ;
DELACRUZ, VF ;
FUERST, TR ;
BURLEIN, JE ;
BENSON, LA ;
BENNETT, LT ;
BANSAL, GP ;
YOUNG, JF ;
LEE, MH ;
HATFULL, GF ;
SNAPPER, SB ;
BARLETTA, RG ;
JACOBS, WR ;
BLOOM, BR .
NATURE, 1991, 351 (6326) :456-460
[29]   Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis [J].
Takiff, HE ;
Cimino, M ;
Musso, MC ;
Weisbrod, T ;
Martinez, R ;
Delgado, MB ;
Salazar, L ;
Bloom, BR ;
Jacobs, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :362-366
[30]  
*WHO, 1999, GLOB TUGB CONTR